Skip to main content

Advertisement

Log in

Therapeutic effect of mefloquine on Schistosoma mansoni in experimental infection in mice

Journal of Parasitic Diseases Aims and scope Submit manuscript

Abstract

Schistosomiasis is one of the most prevalent parasitic infections worldwide. Praziquantel is the drug of choice for treatment of schistosomiasis for its high efficacy. The present work was carried out on 160 mice to evaluate the therapeutic effect of mefloquine on experimental schistosomiasis mansoni. Mice were classified into 3 groups; group I (20 infected non-treated mice), group II included 60 infected mice which were further divided into group IIm (20 mice treated with 400 mg/kg mefloquine), group IIp (20 mice treated with 1,000 mg/kg/2 days praziquantel) and group IIpm (20 mice treated with 200 mg/kg mefloquine and 500 mg/kg praziquantel), group III included 80 non-infected mice subdivided into group IIIn (20 non-treated mice), group IIIm (20 mice treated with 400 mg/kg mefloquine), group IIIp (20 mice treated with 1,000 mg/kg/2 days praziquantel), group IIIpm (20 mice treated with 200 mg mefloquine and 500 mg praziquantel). Mefloquine significantly reduced worm burden, tissue egg load, number of liver granulomas and increased the percent of dead ova within granulomas. Combination of mefloquine and praziquantel gave better curative effects than praziquantel or mefloquine given alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  • Andrade ZA (1965) Hepatic schistosomiasis morphological aspects. In: Propper H, Schifner F (eds) Progress in liver disease. Grune and Stratton, New York, pp 228–242

    Chapter  Google Scholar 

  • Bancroft JD, Steven A (eds) (1975) Histopathological stains and their diagnostic uses. Churchill Living Stone, Edinburgh, pp 7–46

    Google Scholar 

  • Berhe N, Myrvang B, Gundersen SG (2008) Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg 78:228–234

    PubMed  Google Scholar 

  • Cheever AW (1969) Quantitative comparison of the intensity of Schistosoma mansoni infection in man and experimental animals. Trans R Soc Trop Med Hyg 63:781–792

    Article  CAS  PubMed  Google Scholar 

  • Cheever AW, Andrade ZA (1967) Pathological lesions associated with S. mansoni infection in man. Trans R Soc Trop Med Hyg 61:626–639

    Article  CAS  PubMed  Google Scholar 

  • Correa Soares JB, Menezes D, Vannier-Santos MA, Ferreira-Pereira A, Almeida GT, Venancio MT (2009) Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols. PloS Negl Trop Dis 3(7):1–16

    Article  Google Scholar 

  • Cui L, Su XZ (2009) Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther 7:999–1013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dunn MA, Kamel R, Kamel IA, Biampica L, El-Kholy A, Hait PK (1979) Liver collagen synthesis in schistosomiasis mansoni. J Gastroenterol 76:978–982

    CAS  Google Scholar 

  • El-Lakkany NM, Seif el-Din SH, Sabra AA, Hammam OA (2011) Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harboring juvenile and adult Schistosoma mansoni. Mem Inst Oswaldo Cruz Rio J 106(7):814–822

  • El-Meneza SE, Olds GR, Kresina TF, Mahmoud AAF (1989) Dynamics of hepatic connective tissue matrix constituents during murine S. mansoni infection. Hepatology 9:50–56

    Article  CAS  PubMed  Google Scholar 

  • Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis, resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51:83–88

    CAS  PubMed  Google Scholar 

  • Frenzel K, Grigull L, Odongo-Aginya E, Ndugwa CM, Loroni-Lakwo T, Schweigmann U, Vester U, Spannbrucker N, Doehring E (1999) Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. Am J Trop Med Hyg 60:927–931

    CAS  PubMed  Google Scholar 

  • Gryseels B, Mbaye A, de Vlas SJ, Stelma FF, Guisse F (2001) Are poor responses to praziquantel for the treatment of Schistosoma mansoni infection in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6:864–873

    Article  CAS  PubMed  Google Scholar 

  • Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368:1106–1118

    Article  PubMed  Google Scholar 

  • Homeida MA, Tom I, Nash T, Bennett JL (1991) Association of the therapeutic activity of praziquantel with the reversal of Symmers’ fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 45:360–365

    CAS  PubMed  Google Scholar 

  • Ismail M, Botros S, Metwally A, William S, Farghally A (1999) Resistance to praziquantel: direct evidence for Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60:932–935

    CAS  PubMed  Google Scholar 

  • Keiser J, Utzinger J (2007) Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis 20:605–612

    Article  CAS  PubMed  Google Scholar 

  • Keiser J, Chollet J, Xiao SH, Mei JY, Jiao PY, Utzinger J (2009) Mefloquine: an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl Trop Dis 3(1):1–11

    Article  Google Scholar 

  • Keiser J, N’Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, Hatz C (2010a) Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 50(9):1205–1213

    Article  CAS  PubMed  Google Scholar 

  • Keiser J, Vargas M, Doenhoff MJ (2010b) Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice. Am J Trop Med Hyg 82(1):112–114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Keiser J, Manneck T, Vargas M (2011) Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. J Antimicrob Chemother 66(8):1791–1797

    Article  CAS  PubMed  Google Scholar 

  • Lawrence JD (1973) The ingestion of red blood cells by Schistosoma mansoni. J Parasitol 59:60–63

    Article  CAS  PubMed  Google Scholar 

  • Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY, Sun Y, Wang Y, Zhang ZS (2011) New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One 6:e20247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mahmoud AEF, Warren KS (1974) Anti-inflammatory effects of tartar emetic and niridazole: suppression of Schistosome egg granuloma. J Immunol 112:222–228

    CAS  PubMed  Google Scholar 

  • Manneck T, Haggenmüller Y, Keiser J (2010) Morphological effects and tegumental alterations induced by mefloquine on Schistosomula and adult flukes of Schistosoma mansoni. Parasitology 137(1):85–98

    Article  CAS  PubMed  Google Scholar 

  • Manneck T, Braissant O, Ellis W, Keiser J (2011) Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on Schistosomula and adult worms in vitro and in vivo. Exp Parasitol 127(1):260–269

    Article  CAS  PubMed  Google Scholar 

  • Masson P (1929) Some histological methods. Trichrome stain and preliminary technique. Bull intern Assoc Med 12:75

  • Morcos SH, Khayyal MT, Mansour MM, Saleh S, Ishak EA, Girgis NI, Dunn MA (1985) Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am J Trop Med Hyg 34:314–321

    CAS  PubMed  Google Scholar 

  • Ncokazi KK, Egan TJ (2005) A Colorimetric high-throughput beta-haematin inhibition screening assay for use in the search of antimalarial compounds. Anal Biochem 338:306–319

    Article  CAS  PubMed  Google Scholar 

  • Nicolls DJ (2008) Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997–2008. Am J Trop Med Hyg 79:927

    Google Scholar 

  • Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5:941–955

    Article  CAS  PubMed  Google Scholar 

  • Oliveira MF, Timm BL, Machado EA, Miranda K, Attisa M (2002) On the pro-oxidant effects of haemozoin. FEBS Lett 512:139–144

    Article  CAS  PubMed  Google Scholar 

  • Pearce EJ (2005) Priming of the immune response by Schistosome eggs. Parasite Immunol 27(7–8):265–270

    Article  CAS  PubMed  Google Scholar 

  • Pellegrino J, Oliveira CA, Faria J, Cumha AS (1962) New approach to the screening of drugs in experimental Schistosoma mansoni in mice. Am J Trop Med Hyg 11:201–215

    CAS  PubMed  Google Scholar 

  • Peters AP, Warren KS (1969) A rapid method of infecting mice & other laboratory animals with Schistosoma mansoni subcutaneous injection. J Parasitol 55:558–563

    Article  Google Scholar 

  • Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61:294–303

    Article  CAS  PubMed  Google Scholar 

  • Sadun EH, Williams JS (1966) Biochemical aspects of schistosomiasis mansoni in mice in relation to worm burdens and duration of infection. Exp Parasitol 18:266–273

    Article  CAS  Google Scholar 

  • Sanderson L, Bartlett A, Whitfield PJ (2002) In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract towards adult Schistosomes and their egg production. J Helminthol 76:241–247

    Article  CAS  PubMed  Google Scholar 

  • Smith JH, Christie JD (1986) The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 17:333–345

    Article  CAS  PubMed  Google Scholar 

  • Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systemic review, meta-analysis and estimates of people at risk. Lancet Infect Dis 6:411–425

    Article  PubMed  Google Scholar 

  • Stelma FF, Talla I, Sow S, Kongs A, Niang M, Polman K (1995) Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 53:167–170

    CAS  PubMed  Google Scholar 

  • Utzinger J, N’Goran KE, Caffrey CR, Keiser J (2011) From innovation to application: social–ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 120(Suppl. 1):121–137

    Article  Google Scholar 

  • Van Nassauw L, Stephen T, Joeri V, Jean-Pierre T, Jozef V (2008) Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Med Infect Dis 6(5):253–258

    Article  PubMed  Google Scholar 

  • Warren KS (1996) The pathogenesis of clay-pipe-stem cirrhosis in mice with chronic schistosomiasis. Am J Path 49:477–489

    Google Scholar 

  • Warren KS, Boros DL (1975) The Schistosome egg granuloma: a form of cell-mediated immunity. In: Furth RV (ed) Mononuclear phagocytes in immunity, infection and pathology, vol 92. Blackwell Scientific Publications, Oxford, p 112

  • World Health Organization (2010) Guidelines for the treatment of malaria, 2nd edn. WHO Library Cataloguing-in-Publication Data

  • Xiao SH, Zhang CW (2010) Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose. Parasitol Res 107(4):773–781

    Article  PubMed  Google Scholar 

  • Xiao SH, Mei JY, Jiao PY (2009) Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum. Parasitol Res 106(1):131–138

    Article  PubMed  Google Scholar 

  • Xiao SH, Xue J, Shen B (2010) Tegumental alterations of adult Schistosoma japonicum harbored in mice treated with a single oral dose of mefloquine. Chin J Parasitol Parasit Dis 28(1):1–7

    CAS  Google Scholar 

  • Xiao SH, Mei JY, Jiao PY (2011) Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate or praziquantel in treatment of mice infected with Schistosoma japonicum. Parasitol Res 108:399–406

    Article  PubMed  Google Scholar 

  • Yolles TK, Moore DV, De Guisti D, Ripsam CL, Meleney HE (1974) A technique for perfusion of laboratory animals for the recovery of Schistosomes. J Parasitol 33:419–426

    Article  Google Scholar 

  • Zhang CW, Xiao SH, Utzinger J, Chollet J, Keiser J, Tanner M (2009) Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine. Parasitol Res 104(6):1407–1416

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samar Sayed Attia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abou-Shady, O.M., Mohammed, S.S., Attia, S.S. et al. Therapeutic effect of mefloquine on Schistosoma mansoni in experimental infection in mice. J Parasit Dis 40, 259–267 (2016). https://doi.org/10.1007/s12639-014-0489-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12639-014-0489-4

Keywords

Navigation